RaymondThertulienMD

Oncology • Charlotte, NC

Physician

Join to view full profile

Are you Dr. Thertulien?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 86 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
125 Queens Rd Ste 600
Charlotte, NC 28204
Phone+1 980-302-6600

Fax+1 980-302-6605
Is this information wrong?

Summary

Dr. Raymond Thertulien, MD is an oncologist in Charlotte, North Carolina. He is currently licensed to practice medicine in North Carolina, Michigan, and Connecticut. He is affiliated with Novant Health Presbyterian Medical Center, Mission Hospital McDowell, and AdventHealth Hendersonville.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 2001
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1994 - 1997
University of Rochester School of Medicine and DentistryClass of 1994

Certifications & Licensure

NC State Medical License 2007 - 2024
NY State Medical License 1996 - 2023
MI State Medical License 2008 - 2012
CT State Medical License 2005 - 2010
AR State Medical License 2001 - 2006
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Start of enrollment: 2017 May 30
Completed
Phase 3
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

18 citations
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.
David J. Araten, Rosario Notaro, Howard T. Thaler, Nancy A. Kernan, Farid Boulad, Hugo Castro-Malaspina, Trudy N. Small, Andromachi Scaradavou, Susan E. Prockop, Sara ...> ;Haematologica. 2012 Mar 1
10 citations
Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data
Rohit P. Ojha, Raymond Thertulien> ;Annals of Oncology. 2012 Feb 1
53 citations
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Eng Huat Tan, Glenwood D. Goss, Ravi Salgia, Benjamin Besse, David R. Gandara, Nasser H. Hanna, James Chih-Hsin Yang, Raymond Thertulien, Michael S. Wertheim, Julien M...> ;Journal of Thoracic Oncology. 2011 Aug 1
Site-specific relative risks of second primary malignancies among patients with Waldenstrom macroglobulinemia.
Brown Philpot LM, Ojha RP, Felini MJ, Treon SP, Hanzis CA, Hunter ZR, Thertulien R> ;J. Clin. Oncol.. 2011-05-20
RADIATION THERAPY FOR LOCALIZED OR LOCALLY ADVANCED PROSTATE ADENOCARCINOMA AND MYELOMA INCIDENCE IN A POPULATION-BASED COHORT
Rohit P. Ojha, Martha Felini, Karan P. Singh, Mohammed F. Faramawi, Raymond Thertulien> ;BJU International. 2011 Mar 1
16 citations
The association between renal cell carcinoma and multiple myeloma: insights from population‐based data
Rohit P. Ojha, Eva L. Evans, Martha Felini, Karan P. Singh, Raymond Thertulien> ;BJU International. 2010 Nov 23
5 citations
Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma
Rohit P. Ojha, Lindsey M. Brown, Martha Felini, Karan P. Singh, Raymond Thertulien> ;Leukemia & Lymphoma. 2010 Aug 31
24 citations
Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma.
Rohit P. Ojha, Lori A. Fischbach, Yi Zhou, Martha Felini, Karan P. Singh, Raymond Thertulien> ;Cancer Epidemiology. 2010 Jun 1
Prostate-cancer screening.
Rohit P. Ojha, Raymond Thertulien, Lori A. Fischbach> ;The New England Journal of Medicine. 2009 Jul 9
Prostate cancer treatment and risk of acute myeloid leukemia in a population-based prospective cohort.
Ojha RP, Thertulien R, Zhou Y, Fischbach LA> ;J. Clin. Oncol.. 2008-05-20
58 citations
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas...
Bart Barlogie, Guido Tricot, Jeff Haessler, Frits van Rhee, Michele Cottler-Fox, Elias Anaissie, James Waldron, Mauricio Pineda-Roman, Raymond Thertulien, Maurizio Zan...> ;Blood. 2008 Jan 1
1 citations
RE: Abou-Jawde et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma
Rohit P. Ojha, Deepak Prabhakar, Eva L. Evans, Kathryn Lowery, Raymond Thertulien, Lori A. Fischbach> ;Haematologica. 2007 Apr 1
89 citations
Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients.
Marisa H. Miceli, Li Dong, Monica Grazziutti, A. Fassas, Raymond Thertulien, F. van Rhee, Bart Barlogie, Elias Anaissie> ;Bone Marrow Transplantation. 2006 May 1
554 citations
Thalidomide and hematopoietic-cell transplantation for multiple myeloma
Bart Barlogie, Guido Tricot, Elias Anaissie, John D. Shaughnessy, Erik Rasmussen, Frits van Rhee, Athanasios Fassas, Maurizio Zangari, Klaus Hollmig, Mauricio Pineda-R...> ;The New England Journal of Medicine. 2006 Mar 9
4 citations
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation
Choon-Kee Lee, Maurizio Zangari, A. Fassas, Raymond Thertulien, Giampaolo Talamo, Ashraf Badros, Michele Cottler-Fox, F. van Rhee, Bart Barlogie, Guido Tricot> ;Bone Marrow Transplantation. 2006 Mar 1
Progressive clonal cytogenetic changes associated with myeloma relapse after allogeneic transplantation following reduced intensity conditioning.
Lee CK, Zangari M, Fassas A, Cottler-Fox M, van Rhee F, Thertulien R, Talamo G, Barlogie B, Tricot G> ;J. Clin. Oncol.. 2005-06-01
High-dose treatment (HDT) and autologous stem cell transplant (ASCT) in Waldenstrom's macroglobulinemia (WM) patients (pts): A single center experience.
Fassas A, Barlogie B, Ward S, Rasmussen E, van Rhee F, Zangari M, Lee C, Talamo G, Thertulien R, Fox M, Tricot G> ;J. Clin. Oncol.. 2005-06-01
Response to bortezomib (BOR) and bone metabolism in multiple myeloma patients.
Zangari M, Esseltine DL, Najarian K, Elice F, Lee C, Yaccoby S, Thertulien R, Barlogie B, Tricot G> ;J. Clin. Oncol.. 2005-06-01
Results of total therapy 2 (TT 2), a phase III randomized trial, to determine the role of thalidomide (THAL) in the upfront management of multiple myeloma (MM).
Barlogie B, Tricot G, Shaughnessy J, Rasmussen E, Anaissie E, Zangari M, Fassas A, Thertulien R, van Rhee F, Crowley J> ;J. Clin. Oncol.. 2005-06-01
12 citations
Health Care Policy Issues as a Result of the Genetic Revolution: Implications for Public Health
Rohit P. Ojha, Raymond Thertulien> ;American Journal of Public Health. 2005 Mar 1
175 citations
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
Maurizio Zangari, Bart Barlogie, Elias Anaissie, Fariba Saghafifar, Paul Eddlemon, Joth Jacobson, Choon Kee Lee, Raymond Thertulien, Giampaolo Talamo, Teri Thomas, Fri...> ;British Journal of Haematology. 2004 Sep 1
12 citations
Deep Septic Thrombophlebitis: An Unrecognized Cause of Relapsing Bacteremia in Patients With Cancer
Marisa H. Miceli, Rola Atoui, Raymond Thertulien, Bart Barlogie, Elias Anaissie, Ronald C. Walker, Laurie Jones-Jackson> ;Journal of Clinical Oncology. 2004 Apr 15
84 citations
Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant
Choon Kee Lee, Maurizio Zangari, Bart Barlogie, A. Fassas, F. van Rhee, Raymond Thertulien, Giampaolo Talamo, Firas Muwalla, Elias Anaissie, Klaus Hollmig, Guido Tricot> ;Bone Marrow Transplantation. 2004 Apr 1
8 citations
Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.
Athanasios Fassas, Bart Barlogie, Susan Ward, Sundar Jagannath, David H. Vesole, S Mattox, D. Siegel, Firas Muwalla, Maurizio Zangari, Elias Anaissie, Frits van Rhee, ...> ;British Journal of Haematology. 2003 Nov 1
90 citations
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.
Maurizio Zangari, Bart Barlogie, Raymond Thertulien, Joth Jacobson, Paul Eddleman, Louis M. Fink, Athanasios Fassas, Frits van Rhee, Giampaolo Talamo, Choon Kee Lee, G...> ;Clinical Lymphoma. 2003 Jun 1
Join now to see all

Press Mentions

New Oncologist to Practice in Asheville, MarionAugust 12th, 2017
Can Her Life Be Extended or Not? One NC Cancer Patient’s Wait for Medicaid ExpansionSeptember 8th, 2023

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Mission Hospital McDowellMarion, North Carolina
Mission HospitalAsheville, North Carolina
AdventHealth HendersonvilleHendersonville, North Carolina
Novant Health Presbyterian Medical CenterCharlotte, North Carolina